Ciproxin 250mg/5ml oral suspension

Nazione: Regno Unito

Lingua: inglese

Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)

Principio attivo:

Ciprofloxacin

Commercializzato da:

Bayer Plc

Codice ATC:

J01MA02

INN (Nome Internazionale):

Ciprofloxacin

Dosaggio:

50mg/1ml

Forma farmaceutica:

Oral suspension

Via di somministrazione:

Oral

Classe:

No Controlled Drug Status

Tipo di ricetta:

Valid as a prescribable product

Dettagli prodotto:

BNF: 05011200; GTIN: 5010605050169

Foglio illustrativo

036_0
Page 1 of 12
Due to regulatory changes, the content of the following Patient
Information Leaflet may vary from the one found in your medicine pack.
Please compare the 'Leaflet prepared/revised date' towards the end of
the leaflet to establish if there have been any changes.
If you have any doubts or queries about your medication, please
contact
your doctor or pharmacist.
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
CIPROXIN 250 MG/5 ML GRANULES AND SOLVENT FOR ORAL SUSPENSION
Ciprofloxacin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ciproxin is and what it is used for
2.
What you need to know before you take Ciproxin
3.
How to take Ciproxin
4.
Possible side effects
5.
How to store Ciproxin
6.
Contents of the pack and other information
1.
WHAT CIPROXIN IS AND WHAT IT IS USED FOR
Ciproxin contains the active substance ciprofloxacin. Ciprofloxacin is
an antibiotic belonging to the
fluoroquinolone family. Ciprofloxacin works by killing bacteria that
cause infections. It only works
with specific strains of bacteria.
Adults
Ciproxin is used in adults to treat the following bacterial
infections:
036_0
Page 2 of 12

respiratory tract infections

long lasting or recurring ear or sinus infections

urinary tract infections

genital tract infections in men and women

gastro-intestinal tract infections and intra-abdominal infections

skin and soft tissue infections

bone and joint infections

to prevent infections due to the bacterium _Neisseria meningitidis_

ant

Scheda tecnica

OBJECT 1
CIPROXIN SUSPENSION
Summary of Product Characteristics Updated 28-Sep-2017 | Bayer plc
1. Name of the medicinal product
Ciproxin 250 mg/5 mL granules and solvent for oral suspension
2. Qualitative and quantitative composition
5 mL suspension after reconstitution (1 measuring spoon) contains 250
mg ciprofloxacin.
2.5 mL suspension after reconstitution (1/2 measuring spoon) contains
125 mg ciprofloxacin.
Excipients: Sucrose
One measuring spoon (5 mL of suspension) contains approx. 1.4 g of
sucrose.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Granules and solvent for oral suspension.
Appearance before reconstitution:
Granules: white to slightly yellowish granules
Solvent: white to slightly yellowish suspension
4. Clinical particulars
4.1 Therapeutic indications
The Ciproxin 250 mg/5 mL oral suspension is indicated for the
treatment of the following infections (see
sections 4.4 and 5.1). Special attention should be paid to available
information on resistance to
ciprofloxacin before commencing therapy.
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
Adults
• Lower respiratory tract infections due to Gram-negative bacteria
- exacerbations of chronic obstructive pulmonary disease
- broncho-pulmonary infections in cystic fibrosis or in bronchiectasis
- pneumonia
• Chronic suppurative otitis media
• Acute exacerbation of chronic sinusitis especially if these are
caused by Gram-negative bacteria
• Urinary tract infections
• Genital tract infections
- gonococcal uretritis and cervicitis due to susceptible _Neisseria
gonorrhoeae_
- epididymo-orchitis including cases due to susceptible _Neisseria
gonorrhoeae_
- pelvic inflammatory disease including cases due to susceptible
_Neisseria gonorrhoeae_
• Infections of the gastro-intestinal tract (e.g. travellers'
diarrhoea)
• Intra-abdominal infections
• Infections of the skin and soft tissue caused by Gram-negative
bacteria
• Malignant external otitis
• Infections of the bo